Tokumaru Y - Search Results

1

MELK expression in breast cancer is associated with infiltration of immune cell and pathological compete response (pCR) after neoadjuvant chemotherapy.

Oshi M, Gandhi S, Huyser MR, Tokumaru Y, Yan L, Yamada A, Matsuyama R, Endo I, Takabe K. Oshi M, et al. Among authors: tokumaru y. Am J Cancer Res. 2021 Sep 15;11(9):4421-4437. eCollection 2021. Am J Cancer Res. 2021. PMID: 34659896 Free PMC article.

2

Current status and limitations of immunotherapy for breast cancer.

Tokumaru Y, Joyce D, Takabe K. Tokumaru Y, et al. Surgery. 2020 Mar;167(3):628-630. doi: 10.1016/j.surg.2019.09.018. Epub 2019 Oct 14. Surgery. 2020. PMID: 31623855 Free PMC article. Review. No abstract available.

3

Effects of MIR143 on rat sarcoma signaling networks in solid tumors: A brief overview.

Tokumaru Y, Takabe K, Yoshida K, Akao Y. Tokumaru Y, et al. Cancer Sci. 2020 Apr;111(4):1076-1083. doi: 10.1111/cas.14357. Epub 2020 Mar 18. Cancer Sci. 2020. PMID: 32077199 Free PMC article. Review.

4

KRAS signaling enriched triple negative breast cancer is associated with favorable tumor immune microenvironment and better survival.

Tokumaru Y, Oshi M, Katsuta E, Yan L, Satyananda V, Matsuhashi N, Futamura M, Akao Y, Yoshida K, Takabe K. Tokumaru Y, et al. Am J Cancer Res. 2020 Mar 1;10(3):897-907. eCollection 2020. Am J Cancer Res. 2020. PMID: 32266098 Free PMC article.

5

G2M Cell Cycle Pathway Score as a Prognostic Biomarker of Metastasis in Estrogen Receptor (ER)-Positive Breast Cancer.

Oshi M, Takahashi H, Tokumaru Y, Yan L, Rashid OM, Matsuyama R, Endo I, Takabe K. Oshi M, et al. Among authors: tokumaru y. Int J Mol Sci. 2020 Apr 22;21(8):2921. doi: 10.3390/ijms21082921. Int J Mol Sci. 2020. PMID: 32331421 Free PMC article.

6

High Expression of miR-34a Associated with Less Aggressive Cancer Biology but Not with Survival in Breast Cancer.

Tokumaru Y, Katsuta E, Oshi M, Sporn JC, Yan L, Le L, Matsuhashi N, Futamura M, Akao Y, Yoshida K, Takabe K. Tokumaru Y, et al. Int J Mol Sci. 2020 Apr 26;21(9):3045. doi: 10.3390/ijms21093045. Int J Mol Sci. 2020. PMID: 32357442 Free PMC article.

7

High Expression of microRNA-143 is Associated with Favorable Tumor Immune Microenvironment and Better Survival in Estrogen Receptor Positive Breast Cancer.

Tokumaru Y, Asaoka M, Oshi M, Katsuta E, Yan L, Narayanan S, Sugito N, Matsuhashi N, Futamura M, Akao Y, Yoshida K, Takabe K. Tokumaru Y, et al. Int J Mol Sci. 2020 May 1;21(9):3213. doi: 10.3390/ijms21093213. Int J Mol Sci. 2020. PMID: 32370060 Free PMC article.

8

The E2F Pathway Score as a Predictive Biomarker of Response to Neoadjuvant Therapy in ER+/HER2- Breast Cancer.

Oshi M, Takahashi H, Tokumaru Y, Yan L, Rashid OM, Nagahashi M, Matsuyama R, Endo I, Takabe K. Oshi M, et al. Among authors: tokumaru y. Cells. 2020 Jul 8;9(7):1643. doi: 10.3390/cells9071643. Cells. 2020. PMID: 32650578 Free PMC article.

9

Transcriptomic Profile of Lymphovascular Invasion, a Known Risk Factor of Pancreatic Ductal Adenocarcinoma Metastasis.

Takahashi H, Katsuta E, Yan L, Tokumaru Y, Katz MHG, Takabe K. Takahashi H, et al. Among authors: tokumaru y. Cancers (Basel). 2020 Jul 24;12(8):2033. doi: 10.3390/cancers12082033. Cancers (Basel). 2020. PMID: 32722116 Free PMC article.

10

Intratumoral Adipocyte-High Breast Cancer Enrich for Metastatic and Inflammation-Related Pathways but Associated with Less Cancer Cell Proliferation.

Tokumaru Y, Oshi M, Katsuta E, Yan L, Huang JL, Nagahashi M, Matsuhashi N, Futamura M, Yoshida K, Takabe K. Tokumaru Y, et al. Int J Mol Sci. 2020 Aug 11;21(16):5744. doi: 10.3390/ijms21165744. Int J Mol Sci. 2020. PMID: 32796516 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters